HomepageMedicinePharma Pulse 10/18/24: Driving Diversity with the Integrated Research Model, More Treatment Options for Schizophrenia & more Medicine Pharma Pulse 10/18/24: Driving Diversity with the Integrated Research Model, More Treatment Options for Schizophrenia & more admin Posted on October 18, 2024 The latest news for pharma industry insiders. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostWorld Animal Enrichment Day: Everything You Need to Know (Vet-Reviewed) Next PostShopping for a Good Loafer? You Might Also Like Medicine ADRIATIC Trial Demonstrates Significant Survival Benefit in LS-SCLC, Potentially Shaping Future Treatment Standards admin January 30, 2025 Medicine Which Offers the Best Chance for Career Longevity in Biopharma? Q&A with Kerry McKittrick, Co-Director of the Harvard Project on Workforce admin January 3, 2024 Medicine Dexcom Announces Preliminary and Unaudited Revenue For Fourth Quarter and Fiscal Year 2023 admin January 13, 2024 Medicine FDA Approves Alexion’s Voydeya as Add-on Treatment for Adults with Extravascular Hemolysis admin April 1, 2024
Medicine ADRIATIC Trial Demonstrates Significant Survival Benefit in LS-SCLC, Potentially Shaping Future Treatment Standards admin January 30, 2025
Medicine Which Offers the Best Chance for Career Longevity in Biopharma? Q&A with Kerry McKittrick, Co-Director of the Harvard Project on Workforce admin January 3, 2024
Medicine Dexcom Announces Preliminary and Unaudited Revenue For Fourth Quarter and Fiscal Year 2023 admin January 13, 2024
Medicine FDA Approves Alexion’s Voydeya as Add-on Treatment for Adults with Extravascular Hemolysis admin April 1, 2024